In todays blog, Amarantus Diagnostics: Launching our First Product - TopicsExpress



          

In todays blog, Amarantus Diagnostics: Launching our First Product in the Neurodiagnostics Market, CEO Gerald Commissiong expands on the completion of the Fit-for-Purpose validation of the Alzheimers blood diagnostic, LymPro Test announced today and Amarantus goals moving forward. Mr. Commissiong also highlights a recent article published in Bloomberg News describing the landscape for a blood-based diagnostic in Alzheimers disease and the ethical questions surrounding such a tool. Mr. Commissiong believes the timing of this article is ideal, as Amarantus Diagnostics is ready to have a major impact in the field of biomarkers to diagnose Alzheimers disease and potentially, monitor drug response. Read the full blog post available here: bit.ly/1zc1HZH
Posted on: Mon, 22 Dec 2014 16:13:17 +0000

Trending Topics



Recently Viewed Topics




© 2015